Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Phase IIIb Study Shows Benefits of Combining Onglyza with Insulin for Type 2 Diabetes

BMS and AstraZeneca say 52-week data showed dipeptidyl peptidase-4 (DPP-4) plus insulin therapy sustained reductions in HbA1c.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »